Table 1.
The correlation of Piwil1 expression with clinicopathological features in endometrial cancer
| Cases (n) | Piwil1 IS | ||
|---|---|---|---|
| Mean ± SD | P value | ||
| Age | |||
| ≤55 | 34 | 4.9 ± 1.1 | |
| >55 | 49 | 4.9 ± 1.0 | 0.9 |
| FIGO stage | |||
| I – II | 78 | 4.9 ± 1.0 | |
| III - IV | 5 | 6.4 ± 0.9 | 0.005 |
| Histological grade | |||
| G1 - G2 | 73 | 4.9 ± 1.1 | |
| G3 | 10 | 5.5 ± 0.8 | 0.11 |
| Lymphovascular space involvement | |||
| No | 68 | 4.8 ± 1.0 | |
| Yes | 15 | 5.9 ± 0.8 | 0.00 |
| Lymph node metastasis | |||
| No | 79 | 4.9 ± 1.1 | |
| Yes | 4 | 6.3 ± 1.0 | 0.03 |
| Myometrial invasion | |||
| ≤1/2 | 70 | 4.9 ± 1.0 | |
| >1/2 | 13 | 5.7 ± 1.2 | 0.02 |
Significance of difference (P value) between categories was analyzed by Mann–Whitney U test. P < 0.05 for the significance of difference